Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Dyslipidemia is an independent risk factor for type 2 diabetes, although exactly which of the many plasma lipids contribute to this remains unclear. We therefore investigated whether lipid profiling can inform diabetes prediction by performing liquid chromatography/mass spectrometry-based lipid profiling in 189 individuals who developed type 2 diabetes and 189 matched disease-free individuals, with over 12 years of follow up in the Framingham Heart Study. We found that lipids of lower carbon number and double bond content were associated with an increased risk of diabetes, whereas lipids of higher carbon number and double bond content were associated with decreased risk. This pattern was strongest for triacylglycerols (TAGs) and persisted after multivariable adjustment for age, sex, BMI, fasting glucose, fasting insulin, total triglycerides, and HDL cholesterol. A combination of 2 TAGs further improved diabetes prediction. To explore potential mechanisms that modulate the distribution of plasma lipids, we performed lipid profiling during oral glucose tolerance testing, pharmacologic interventions, and acute exercise testing. Levels of TAGs associated with increased risk for diabetes decreased in response to insulin action and were elevated in the setting of insulin resistance. Conversely, levels of TAGs associated with decreased diabetes risk rose in response to insulin and were poorly correlated with insulin resistance. These studies identify a relationship between lipid acyl chain content and diabetes risk and demonstrate how lipid profiling could aid in clinical risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, specific TAGs containing palmitate or stearate, i.e. TAG 48:0, 50:0, 48:1 and 50:1, have been associated with the severity of MASLD and with an increased risk of developing T2D.105,106”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES
Nakamura, M. T., & Nara, T. Y. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.121803.063211 · Cited by 1,073
Guillou, H., Zadravec, D., Martin, P. G. P., & Jacobsson, A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.002 · Cited by 865
Invited Review: Effects of acute exercise and exercise training on insulin resistance
Henriksen, E. J. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01219.2001 · Cited by 535
Research works printed but not linked: 1
- German, 2007, Curr Opin Lipidol., 18, 66
Cited by
Items 501–600 of 658
Marron, M. M., Moore, S. C., Wendell, S. G., Boudreau, R. M., Miljkovic, I., Sekikawa, A. M., & Newman, A. B. (2021) · GeroScience · doi:10.1007/s11357-021-00382-6 · Cited by 5
“In addition, we previously found triacylglycerols consisting mostly of polyunsaturated fatty acids were higher among older adults with high versus low walking ability [29], and others have noted these metabolites associated with less insulin resistance [35], lower waist circumference [35], and lower type 2 diabetes ri…”
BackgroundBastaki, K., Umlai, U. I., & Jithesh, P. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99924-3.00004-2 · Cited by 5
Hibernation and plasma lipids in free-ranging brown bears–implications for diabetes
Tekin, H., Fröbert, O., Græsli, A. R., Kindberg, J., Bilgin, M., & Buschard, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291063 · Cited by 6
Li, H., Li, L., Huang, Q.-Q., Yang, S.-Y., Zou, J., Xiao, F., Qin, X., Liu, X., & Yu, R. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i5.1021 · Cited by 6
Shang, J., Castro‐Perez, J. M., Shen, X., Zhu, Y., Liu, H., Qian, Y., Previs, S. F., Howard, A. D., Erion, M. D., Kelley, D. E., et al. (2016) · Obesity · doi:10.1002/oby.21583 · Cited by 5
“identified a TAG signature for insulin resistance in humans that is comprised of TAG of low carbon number and double bond content (9).”
BackgroundMetabolic Signature of CKD: The Search Continues
Mathew, A. V., & Pennathur, S. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.05.005 · Cited by 5
Zeleznik, O. A., Kang, J. H., Lasky-Su, J. A., Eliassen, A. H., Frueh, L., Clish, C. B., ROSNER, B. A., Elze, T., Hysi, P. G., Khawaja, A. P., et al. (2022) · medRxiv · doi:10.1101/2022.02.24.22271483 · Cited by 5
“Triglycerides that are shorter and more saturated were adversely associated while those that are longer and are more unsaturated were inversely associated with POAG, possibly because such triglycerides may be markers of a healthier cardiometabolic profile.(28) Finally, triglycerides showed stronger associations with P…”
BackgroundSelf-citationCirculating lipidome underpins gender differences in the pathogenesis of type 2 diabetes
Rout, M., Fiehn, O., & Sanghera, D. K. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100816 · Cited by 4
“Some studies indicate lower LPC levels in insulin resistance (53, 54).”
Ahmed, M., Saeed, A., Khan, M. Z., Javaid, S., Aslam, F., & Dar, S. I. (2023) · Cureus · doi:10.7759/cureus.44709 · Cited by 7
“Insulin plays a crucial role in fatty acid metabolism, and factors such as diabetes, low insulin levels, and insulin resistance can influence lipid compositions [7,8].”
BackgroundChe, X., Hong, X., Gross, S. M., Pearson, C., Bartell, T. R., Wang, X., & Wang, G. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.01.022 · Cited by 5
Yazdani, A., Méndez-Giráldez, R., Yazdani, A., Wang, R.-S., Schaid, D. J., Kong, S. W., Hadi, M. R., Samiei, A., Samiei, E., Wittenbecher, C., et al. (2024) · Metabolomics · doi:10.1007/s11306-024-02141-y · Cited by 4
“…platforms were applied to measure metabolites in the plasma samples: (1) amino acids and amines (AAA) (Wang et al., 2011), (2) bile acids, organic acids, nucleotides, sugars, and other intermediary metabolites (BONS) (Wang et al., 2013), and (3) lipids of varying classes (Rhee et al., 2011).”
Self-citationQuaytman, J., David, N. L., Venugopal, S., Amorim, T., Beatrice, B., Toledo, F. G. S., Miller, R. G., Steinhauser, M. L., & Fazeli, P. K. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107698 · Cited by 4
Jiang, Y. C., Che, Q., Lu, X., Liu, M., Yao, Y., Cao, X., Li, X., Zhan, Y., Dong, X., Cheng, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1464171 · Cited by 4
Kryska, A., Sawic, M., Depciuch, J., Sosnowski, P., Szałaj, K., Paja, W., Khalavka, M., & Sroka‐Bartnicka, A. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102804 · Cited by 4
Werner, P., Meiss, E., Scheja, L., Heeren, J., & Fischer, M. J. (2017) · Metabolomics · doi:10.1007/s11306-017-1181-3 · Cited by 4
Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study
Irvin, M. R., Montasser, M. E., Kind, T., Fan, S., Barupal, D. K., Patki, A., Tanner, R. M., Armstrong, N. D., Ryan, K. A., Claas, S. A., et al. (2021) · Nutrients · doi:10.3390/nu13114000 · Cited by 4
“Many studies have already demonstrated the utility of lipidomics for biomarker discovery related to CVD [23,24].”
BackgroundInfluentialElingaard-Larsen, L. O., Villumsen, S. O., Justesen, L., Thuesen, A. C. B., Kim, M. G., Ali, M., Danielsen, E. R., Legido‐Quigley, C., van Hall, G., Hansen, T. F., et al. (2023) · Nutrients · doi:10.3390/nu15071590 · Cited by 4
“Our finding of TGs and PCs with relatively fewer double bonds, reflecting increased saturation, as well as shorter carbon-chain length, in the LBW subjects w/NAFLD compared with LBW and NBW subjects without NAFLD, is in agreement with previous studies of NAFLD individuals [12,13,48,51].”
BackgroundResultSulis, P. M., Mendes, A. K. B., Fernandes, T. A., Frederico, M. J. S., Rey, D. P., Aragón, D. M., Ruparelia, K. C., & Silva, F. R. M. B. (2023) · Biochimie · doi:10.1016/j.biochi.2023.04.006 · Cited by 6
Toth, P. P. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.06.038 · Cited by 4
de Sander, M. F., Becker, S., Thiery, J., & Ceglarek, U. (2014) · Chromatographia · doi:10.1007/s10337-014-2782-x · Cited by 4
“The identification of TG molecular species from biological samples is challenging because of the great variability of the FAs relating to the degree of saturation and chain length, with the predominant FAs containing C16, C18, or C20.”
BackgroundInfluentialLipid Informatics: From a Mass Spectrum to Interactomics
Ejsing, C. S., Husen, P., & Tarassov, K. (2012) · Wiley eBooks · doi:10.1002/9783527655946.ch8 · Cited by 6
Understanding the Lipidome at the Systems Level with lipidomeRPreprint
Suvitaival, T., & Legido‐Quigley, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.16.994061 · Cited by 4
Myrmel, L. S., Fjære, E., Han, M., Jensen, B. A. H., Rolle-Kampczyk, U. E., Danneskiold‐Samsøe, N. B., Ho, Q. T., Smette, A., von Bergen�, M., Xiao, L., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400246 · Cited by 3
Chen, L., Dai, J. M., Yu, G., Pang, W. W., Rahman, M. L., Liu, X., Fiehn, O., Guivarch, C., Chen, Z., & Zhang, C. (2024) · Nutrients · doi:10.3390/nu16040492 · Cited by 3
“TGs and PCs with different acyl chains and double bonds have different biological functions, but the exact health effects of each or the combination of these lipid metabolites are still poorly understood [51,52].”
BackgroundIntroduction to Clinical Applications of Biomolecules in Disease Diagnosis
Singh, P. K., Rayeen, F., Pathak, N., & Singh, R. L. (2024) · Springer eBooks · doi:10.1007/978-981-97-4723-8_1 · Cited by 3
Janikiewicz, J., Pawelec, P., Kucharczyk, P., & Dobrzyń, A. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_127 · Cited by 3
Hameed, A., Adamska-Patruno, E., Godzień, J., Czajkowski, P., Krasowska, U., Pietrowska, K., Fiedorczuk, J., Moroz, M., Bauer, W., Siemińska, J., et al. (2022) · Nutrients · doi:10.3390/nu14204305 · Cited by 3
“These findings are consistent with the results of another published study illustrating the lipidome of people with obesity and prediabetes, which reported perturbations in the levels of several PL, LPC, LPE, LPI, SM, and ceramides in people with obesity [26].”
ResultWang, W., Liu, L., Qiu, W., Chen, C., Huang, Y., Cai, A., Nie, Z., Ou, Y., Zhu, Y., & Feng, Y. (2024) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s465135 · Cited by 3
“…Previous studies have shown that a set of triglycerides rather than total triglycerides were risk predictors of cardiovascular diseases or related risk factors, 28,29 suggesting that the relevance between triglycerides and ischemic stroke may be inaccurately estimated by using total triglycerides.”
BackgroundDavid, C., Deschênes, S., Ichkhan, G., Daneault, C., Frayne, I. R., Bouchard, B., Forest, A., Shi, Y. F., Higgins, M., Sirois, M. G., et al. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00841.2024 · Cited by 3
Imam, N., Hussain, M. S., Hassan, M. N., Aziz, T., Naseem, N., Ahmad, M. F., Siddiqui, W. A., & Khan, R. H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.09.015 · Cited by 4
Using metabolomics to identify biomarkers for metabolic diseases
Sébédio, J. L., & Polakof, S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-78242-084-2.00008-3 · Cited by 5
A Synthetic Wide-Bandwidth Radar System Using Software Defined Radios
Toker, O., & Özdemir, Ö. (2020) · International Electronic Conference on Sensors and Applications (ECSA) · doi:10.3390/ecsa-7-08174 · Cited by 3
Role of Microbiota in Regulating Host Lipid Metabolism and Disease Risk
Bondia‐Pons, I., Hyötyläinen, T., & Orešič, M. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_12 · Cited by 5
Shaping the Future of Personalized Nutrition with Metabolomics
Scherer, M., Ross, A. B., Moco, S., Collino, S., Martin, F., Godin, J., Kastenmayer, P., & Rezzi, S. (2013) · Wiley eBooks · doi:10.1002/9781118537282.ch10 · Cited by 3
Pavlic, M., & Lewis, G. F. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834b0d6c · Cited by 3
Self-citationBalderas, C., Ocariz, M. G., Rogova, O., Al‐Majdoub, M., Björck, I., Tovar, J., & Spégel, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1236153 · Cited by 2
“Whether the health-promoting lipid signature, which is also observed in other weight loss interventions (8, 16), is targetable via modulation desaturase and elongase activity remains to be elucidated.”
Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community
Florea, V. V., Gajjar, P., Huang, S., Tang, J., Zhao, S., Davenport, M., Mi, M., Haff, M. G., Zhang, X., Miller, P. E., et al. (2024) · Liver International · doi:10.1111/liv.16147 · Cited by 2
Self-citationYao, S., Marron, M. M., Farsijani, S., Miljkovic, I., Tseng, G. C., Shah, R. V., Murthy, V. L., & Newman, A. B. (2025) · Aging Cell · doi:10.1111/acel.70181 · Cited by 2
“…et al. 2021; Gonzalez-Covarrubias 2013; Wallner et al. 2018), glucose metabolism or insulin resistance (Guasch-Ferre et al. 2016; Long et al. 2020; Rhee et al. 2011), and kidney function (Drechsler et al. 2013; Tomaschitz et al. 2014; Yamaguchi et al. 2021) may precede unintentional weight loss…”
Qiu, Y., Liu, S., Wang, L., Jiang, Z., & Yang, X. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.06.035 · Cited by 2
Metabolomic signatures of dietary carbohydrates and differential association with type 2 diabetes
Wang, X., Xia, P., Wang, F., Wu, Z., Hu, Y., Eliassen, A. H., Zeleznik, O. A., Bhupathiraju, S. N., Mousavi, S. M., Prentice, R. L., et al. (2026) · Nature Health · doi:10.1038/s44360-025-00023-8 · Cited by 3
“This finding aligns with previous studies that have reported an association between lipids with lower carbon numbers and fewer double bonds and an increased risk of diabetes 25,26 .”
A non-targeted metabolomics study on different glucose tolerance states
Gu, Y., Zang, P., Li, L., Zhang, H., Li, J., Li, J., Yan, Y., Sun, S.-M., Wang, J., & Zhu, Z.-Y. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0662-x · Cited by 3
Big Data and Precision Medicine
Piaggi, P. (2023) · New paradigms in healthcare · doi:10.1007/978-3-031-23852-9_9 · Cited by 2
Mechanisms of Nerve Injury in Diabetes: Dyslipidemia, Bioenergetics, and Oxidative Damage
Eid, S., Noureldein, M. H., Savelieff, M. G., & Feldman, E. L. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_16 · Cited by 2
Ben‐Aicha, S., Srivastava, P. K., Kararigas, G., Devaux, Y., Emanueli, C., & Sopić, M. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100091 · Cited by 2
Liver Transplantation Biomarkers in the Metabolomics Era
Cortes, M., García‐Cañaveras, J. C., Pareja, E., & Lahoz, A. (2016) · Biomarkers in disease · doi:10.1007/978-94-007-7742-2_42-1 · Cited by 2
A methodology for elucidating regulatory mechanisms leading to changes in lipid profiles
Pinto, F. C., Ravipati, S., Barrett, D. A., & Hodgman, C. T. (2017) · Metabolomics · doi:10.1007/s11306-017-1214-y · Cited by 2
“2013), apply advanced statistics to classify profiles into high or low risk of suffering a disease (Rhee et al. 2011), manually construct a network between known disease-associated genes, signal-transduction Abstract Introduction It is difficult to elucidate the metabolic and regulatory factors causing lipidome pertur…”
Tissue-specific insulin resistance in human obesity: A physiological approach to lipid metabolism
van der Kolk (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180503bk · Cited by 2
Dynamic Lipidomic Remodeling and Clinical Correlations after Sleeve Gastrectomy in Obese Subjects
Lee, G., Lee, Y. C., Park, M., Kim, S. M., Park, J.-H., & Lee, D. H. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0120 · Cited by 2
“These findings suggest that the SG-induced TG remodeling not only reflects improved lipid utilization but may also contribute to the broader metabolic benefits, including reductions in fat accumulation and improvements in insulin sensitivity [13,32-34].”
Introduction to Metabonomics in Systems Biology Research
Martin, F., & Kochhar, S. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_1 · Cited by 1
Wang, S., Wang, W., Mao, H., Zhu, M., Xu, Z., Wang, J., Zhang, X., Li, B., Xiang, X., & Wang, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.887757 · Cited by 2
“They replaced sucrose in AIN-93 feed with a portion of inulin for their diet without balancing the energy and macronutrients in the diet (42).”
MethodDu, J., Ge, X., Li, W., Wang, J., Zhang, Z., Jiang, X., Shao, K., Peng, W., Wang, X., Guo, X., et al. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01408-3 · Cited by 1
“For example, elevated bulk triglycerides have been used as indicators of increased risk for T2D development [17].”
Ireland, R. A., Tse, B. C. Y., Ashhurst, A. S., Don, A. S., & Byrne, S. N. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.11.030 · Cited by 1
Yao, S., Mao, Z., Marron, M. M., Simonsick, E. M., Murthy, V. L., Shah, R. V., & Newman, A. B. (2025) · Metabolites · doi:10.3390/metabo15050334 · Cited by 1
Dev, P. K., Leszczynski, E. C., Schwartz, C. S., Barber, J. L., Ayala, E. J., Wang, X., Fairman, C. M., Ghosh, S., Gerszten, R. E., Olivier, M., et al. (2025) · Metabolomics · doi:10.1007/s11306-025-02330-3 · Cited by 1
“In contrast, the molecular weight of each LPC, LPE, CE, and SM analyte identifies a specific acyl chain length and saturation (Rhee et al., 2011).”
Self-citationCleveland, K. H., Scholpa, N. E., & Schnellmann, R. G. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103698 · Cited by 2
Brøns, C., Elingaard-Larsen, L. O., Justesen, L., Villumsen, S. O., Thuesen, A. C. B., Engelhard, L. M., Gertsen, S. S., Ried‐Larsen, M., Prasad, R. B., Hansen, T. F., et al. (2025) · Diabetes · doi:10.2337/db25-0307 · Cited by 1
Metabolomics and Genomics in Endocrinology
Bandarian, F., Dehghanbanadaki, H., Khashayar, P., Rezaei–Tavirani, M., Amoli, M. M., Panahi, N., Bandarian, M., & Razi, F. (2025) · Springer eBooks · doi:10.1007/978-981-95-2286-6_7 · Cited by 1
Fu, T., Francis, E. C., Kinkade, C. W., SPERLING, R. S., Qiu, Y., Kurland, I. J., Jao, J. K., & Shiau, S. (2025) · Metabolites · doi:10.3390/metabo15120765 · Cited by 1
“TAGs with shorter carbon chains (e.g., 41–52 carbons) and fewer double bonds (e.g., 0–4) tend to be composed of saturated (14:0, 16:0, 18:0) and monounsaturated (18:0) fatty acids [27].”
Plasma metabolomic signature of breastfeeding and risk of cardiometabolic diseases
Birukov, A., Lin, N., Mongiovi, J. M., Razquín, C., Wang, F., Semnani‐Azad, Z., Tessier, A., Guasch‐Ferré, M., Ley, S. H., Manson, J. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65977-5 · Cited by 2
Pearson, M. J., Willency, J. A., Lin, Y., Abadi, A., Hartman, M. L., Coşkun, T., Ruotolo, G., Duffin, K. L., Haupt, A., Newgard, C. B., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag201
Personalized Diet and Lifestyle Interventions on Lipids and Lipoproteins
Zheng, Y., & Qi, L. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00001-9 · Cited by 1
Qing, Q., Huang, L., Sun, W., Chen, J., Yu, N., Chen, Y., Xu, D., & Zhao, M. (2021) · Biomedical Chromatography · doi:10.1002/bmc.5234 · Cited by 1
Mass Spectrometry-Based Lipidomics for Biomarker Research
Hu, C., Li, J., & Xu, G. (2014) · Springer eBooks · doi:10.1007/978-94-007-7740-8_36-1 · Cited by 1
Visualizing biomarkers and their association with clinical outcomes: A machine learning approach
Zheng, H., Gerszten, R. E., & Corey, K. E. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106005 · Cited by 1
Self-citationMultiomics Approaches Identify Biomarkers for BAT Thermogenesis
Zhang, L., Ma, P., Wang, Z., Xu, T., Lam, S. M., Shui, G., Wang, Y., Xie, J., & Qiang, G. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00423 · Cited by 1
de Oliveira, J. M., Dualib, P. M., Ferraro, A. A., Mattar, R., Dib, S. A., & de Almeida-Pititto, B. (2024) · Metabolites · doi:10.3390/metabo14110608 · Cited by 3
“These changes include downregulation of triacylglycerols and diacylglycerols and upregulation of phospholipids and sphingolipids, a profile that is consistent with suppression of endogenous lipogenesis [4,55].”
Metabolomics Profiles of Eating Disorders
Monteleone, A. M., & Monteleone, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-46096-8_42 · Cited by 1
Metabonomics in Clinical Practice
Collino, S., Martin, F., & Moco, S. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_2 · Cited by 1
Lee, S., Kim, K., Kwon, H. S., Kim, Y. E., Kim, K. Y., Jeong, J., Oh, H. B., Kim, T., Hong, J., & Kang, D. (2019) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.11703 · Cited by 1
Liver Transplantation Biomarkers in the Metabolomics Era
Cerisuelo, M. C., García‐Cañaveras, J. C., Pareja, E., & Lahoz, A. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7675-3_42 · Cited by 3
Metabolomics and Its Role in the Study of Mammalian Systems
Dunn, W. B., Mamas, M. A., & Heazell, A. E. P. (2013) · Wiley eBooks · doi:10.1002/9783527655861.ch14 · Cited by 1
Lipidomics for Health and Disease
(2016) · Wiley eBooks · doi:10.1002/9781119085263.ch17 · Cited by 1
Non-invasive monitoring and classification of coronary heart disease by metabolomics and lipidomicsPreprint
Wang, Z., Yan, C., Li, Y., Zhang, Y., Hu, J., Xu, Y., Liu, L., & Liu, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3577837/v1 · Cited by 1
Алексеевна, А. В., Ta, R., & Титов, В. Н. (2013) · Клиническая лабораторная диагностика
Mass Spectrometry-Based Lipidomics for Biomarker Research
Hu, C., Li, J., & Xu, G. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7696-8_36
The role of hepatic FoxO1 in insulin resistance
Ling, A. V. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Fanos, V., & Cuzzolin, L. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_7 · Cited by 1
Science of bariatric surgery in focus
Inge, T. H., & D’Alessio, D. A. (2011) · Diabetes Management · doi:10.2217/dmt.11.72
Metabolomics analyses to better understand complex phenotypes
Yu, Z. (2013) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17273 · Cited by 1
Biomarkers and prediction models for type 2 diabetes and diabetes related outcomes
Abbasi, A. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Shotgun Lipidomics in der biomedizinischen und klinischen Forschung
Klose, C. D., & Coskun, Ü. (2016) · BIOspektrum · doi:10.1007/s12268-016-0739-3
“Nat Immunol 17:844–850 [5] Rhee EP, Cheng S, Larson MG et al.”
BackgroundHealthy Dietary Patterns, Plasma Lipid Metabolites, Cardiovascular Health and Mortality
Wang, D. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Effects of Butter and Phytanic acid intake on metabolic parameters and T-cell polarization
Drachmann, T., Hellgren, L. I., & Brix, S. (2012)
Using a Multi-Omic Approach to Investigate a Diet Intervention in Young Adults at Risk of Disease
Famodu, O. A. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7083
“So far in the metabolomics field, researchers have identified serum amino acids, mostly branched-chain amino acids (BCAAs) [77] and triacylglycerols with low carbons and double bonds [78] to be associated with insulin resistance and future metabolic abnormalities.”
BackgroundSpecial Issue: Systems Approach to Metabolic Disease
Hyötyläinen, T. (2015)
Drug Development for Diabetes Mellitus: Beyond Hemoglobin A1c
Bril, F., Iruarrizaga‐Lejarreta, M., & Alonso, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_15
Advanced Metabolomics for Metabolic Syndrome/Metabolic Diseases
Sun, X., & Zhu, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22893-x
Development of a Pediatric Model of Nafld in Neonatal Iberian Pigs
Hernandez, G. V. (2019) · DigitalCommons - CalPoly (California State Polytechnic University) · doi:10.15368/theses.2019.107
Searching for biomarkers of non-alcoholic fatty liver disease and metabolic syndrome
delaCruz‐Villar, L. (2020) · Communities in ADDI (University of the Basque Country)
Gu, X. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-7mah-k592
Molecular biology and genomics — the basis of health and the future of precision medicine
Mereuţă, I. (2021) · Bulletin of the Academy of Sciences of Moldova Medical Sciences · doi:10.52692/1857-0011.2021.2-70.08
(2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283558773
Aguilar-Salinas, C. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734059638.793558319
Daniel, H. (2013) · Wiley eBooks · doi:10.1002/9783527655861.ch16
Biomarkers in Disease: Diabetes Methods, Discoveries and Applications
de Carvalho, L. S. F., Asari, A. I. A., Teles, B. S. B. D. S., Chaves‐Filho, A. B., & Yoshinaga, M. Y. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_20-1
Кушнарьова, Н. М., Зінич, О., Прибила, О., Ковальчук, А., Korpachev, V. V., & Shyshkan-Shyshova, К. О. (2022) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2022.3.04
Biomarkers in Disease: Diabetes Methods, Discoveries, and Applications
de Carvalho, L. S. F., Asari, A. I. A., Teles, B. S. B. D. S., Filho, A. D. B. C., & Yoshinaga, M. Y. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_20
Precision Nutrition and Metabolomics, a Model of Alzheimer’s Disease
Ledinger, S., Ludwig-Papst, C., & Scheffler, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-10153-3_7
Metabolomics Profiles of Eating Disorders
Monteleone, A. M., & Monteleone, P. (2023) · Springer eBooks · doi:10.1007/978-3-030-97416-9_42-1
Lin, P., Pan, Y., Wan, L., Miao, L., Lin, S., Cao, L., & Wang, L. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4614604
Metadata
- Authors
- Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E.
- Affiliations
- Broad Institute (US)
- Boston University (US)
- Massachusetts General Hospital (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1402-1411
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069773
- OpenAlex
- W2169156123
- Cited by
- 647
- References
- 33
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 48 · 2023: 54 · 2022: 65 · 2021: 57 · 2020: 52 · 2019: 47 · 2018: 38 · 2017: 41 · 2016: 44 · 2015: 33 · 2014: 40 · 2013: 45 · 2012: 25
- FWCI
- 31.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation (N01-HC-25195)
- Donald W. Reynolds Foundation
- American Heart Association (N01-HC-25195)
- Endocrine Fellows Foundation
- Fondation Leducq
- National Institutes of Health (n01hc025195-11-0-0, N01-HC 25195)
- National Heart, Lung, and Blood Institute (N01‐HC25195, R01HL081572, N01-HC-025195, K23HL091106)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088214, T32-DK-00754023, T32DK007540, R01-DK-HL-081572, R01DK081572)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- type 2 diabetes, insulin resistance, triglycerides, lipidomics, plasma lipids, acyl chain length, double bond content, dyslipidemia, diabetes risk prediction, oral glucose tolerance test, insulin action, acute exercise
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Exercise Test, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Molecular Structure, Biomarkers, Case-Control Studies, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.